ARCHIVES

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

This article is from The Cancer Letter archive.

Vol. 20 No. 04 | January 28, 1994

Download PDF Visit The Full Archive

Related Articles

DCPC Bard Approves Concepts For New Grant Programs

November 13, 1992

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994